MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment.
MUC1-C 在耐药性 HR+/HER2- 乳腺癌中的依赖性，为抗体药物偶联物治疗提供了新的靶点
期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-025-00751-w
Nakashoji Ayako, Bhattacharya Atrayee, Ozawa Hiroki, Haratake Naoki, Shigeta Keisuke, Fushimi Atsushi, Yamashita Nami, Matsui Akira, Kure Shoko, Kameyama Tomoe, Takeuchi Makoto, Fukuda Kazumasa, Yokoe Takamichi, Nagayama Aiko, Hayahsida Tetsu, Kitagawa Yuko, Liu Renyan, Giordano Antonio, Jeselsohn Rinath, Shapiro Geoffrey I, Kufe Donald
